Tatva Chintan Pharma Chem
TATVANSE

Tatva Chintan Pharma Chem

₹1,078.90-24.90 (2.26%)1D
1D
1W
1M
3M
6M
1Y
3Y
5Y
All
Create Stock SIPAutomate your investments in this
Overview
Technicals
News
Events

Performance

Today’s low
1,055.20
Today’s high
1,098.10
52 week low
633.55
52 week high
1,610.00
Open price
1,074.40
Previous close
1,103.80
Live volume
15,038
Lower circuit
883.10
Upper circuit
1,324.50

Fundamentals

Market Cap
₹2,573Cr
ROE
2.35%
P/E Ratio(TTM)
78.50
EPS(TTM)
14.01
P/B Ratio
3.41
Dividend Yield
0.09%
Industry P/E
36.15
Book Value
322.50
Debt to Equity
0.11
Face Value
10

Financials

*All values are in Rs. Cr
No Graph Data To Display
Quarterly
Yearly

About

Tatva Chintan Pharma Chem Limited manufactures specialty chemicals, phase transfer catalysts, and pharmaceutical intermediates.;
MD/CEO
Chintan Nitinkumar Shah
Founded in
1996
NSE symbol
TATVA
Industry

Shareholding Pattern

Dec '24
Mar '25
Jun '25
Sep '25
Dec '25
Promoters
72.02%
Retail And Others
20.48%
Foreign Institutions
4.17%
Mutual Funds
3.25%
Other Domestic Institutions
0.07%

Mutual Funds Invested (1)

Similar stocks

StockMkt price (1D)52 week performanceMarket capP/E ratioP/B ratio
₹255.75
-4.10 (1.58%)
L
    H
    4,108.48-14.23139.77
    ₹1,980.00
    +3.30 (0.17%)
    L
      H
      3,943.5252.6811.61
      EpigralEPIGRAL
      ₹867.85
      -1.20 (0.14%)
      L
        H
        3,751.1411.11.79
        ₹499.40
        +2.25 (0.45%)
        L
          H
          3,356.0024.363.35
          Livesquawk
          Tatva Chintan Pharma faces 80% gas supply limit due to govt rules. Company actively exploring alternative fuel options to tackle issue.
          Livesquawk
          Tatva Chintan projects INR 200-250 crore revenue from new agro, pharma intermediates by 2027.
          Livesquawk
          Tatva Chintan expects electrolyte salts to contribute 7-8% of revenue by 2026, up from 1%. This marks a significant growth in their revenue projection as per concall update.
          Livesquawk
          Tatva Chintan Pharma Chem plans a new greenfield plant at Jolva with a CapEx of INR250-275 crores. The project execution is slated for 18 months, with groundbreaking in the current quarter.
          2026
          21
          Jan
          Quarterly Result
          Release date
          2025
          31
          Oct
          Quarterly Result
          Release date

          12
          Sep
          Dividend
          Ex date
          ₹1.00
          per share

          For each share you hold, you will receive ₹1.00
          Dividend amount₹1.00 per share
          Dividend TypeFinal
          Ex Date12 Sep ‘25
          Record Date12 Sep ‘25
          Announcement date2 May ‘25
          24
          Jul
          Quarterly Result
          Release date

          2
          May
          Dividend
          Announced
          ₹1.00
          per share

          For each share you hold, you will receive ₹1.00
          Dividend amount₹1.00 per share
          Dividend TypeFinal
          Ex Date12 Sep ‘25
          Record Date12 Sep ‘25
          Announcement date2 May ‘25
          2024

          6
          Sep
          Dividend
          Ex date
          ₹2.00
          per share

          For each share you hold, you will receive ₹2.00
          Dividend amount₹2.00 per share
          Dividend TypeFinal
          Ex Date6 Sep ‘24
          Record Date7 Sep ‘24
          Announcement date3 May ‘24

          3
          May
          Dividend
          Announced
          ₹2.00
          per share

          For each share you hold, you will receive ₹2.00
          Dividend amount₹2.00 per share
          Dividend TypeFinal
          Ex Date6 Sep ‘24
          Record Date7 Sep ‘24
          Announcement date3 May ‘24
          Events calendar
          View upcoming events in other stocks